Cargando…
Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer
Breast cancer is a global health issue. For decades, breast cancer was classified into many histological subtypes on the basis of microscopic and immunohistochemical evaluation. The discovery of many key genomic driver events involved in breast cancer carcinogenesis resulted in a better understandin...
Autores principales: | El Hachem, Georges, Gombos, Andrea, Awada, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492227/ https://www.ncbi.nlm.nih.gov/pubmed/31069063 http://dx.doi.org/10.12688/f1000research.17542.1 |
Ejemplares similares
-
Recent advances in managing triple-negative breast cancers
por: Bengala, Carmelo
Publicado: (2009) -
Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019) -
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
por: Barton, Maria, et al.
Publicado: (2019) -
Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019) -
Recent advances in nanotheranostics for triple negative breast cancer treatment
por: Thakur, Vikram, et al.
Publicado: (2019)